Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2017 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol. 2018 Jan;19(1):127-138. doi: 10.1016/S1470-2045(17)30715-5. Epub 2017 Nov 17.
Lancet Oncol. 2018.
PMID: 29158011
Clinical Trial.
Cost Effectiveness Analysis of Everolimus + Exemestane for Patients with Advanced Breast Cancer with Positive Estrogen Receptor (ER +), HER2-, Refractory to Non-Steroidal Aromatase Inhibitors (NSAIS) in Chile.
Ratto B, Torres UR, Cerda VH, Anaya P.
Ratto B, et al. Among authors: torres ur.
Value Health. 2014 Nov;17(7):A634. doi: 10.1016/j.jval.2014.08.2273. Epub 2014 Oct 26.
Value Health. 2014.
PMID: 27202256
Free article.
No abstract available.
Item in Clipboard
Cite
Cite